Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 151 results:
Συντάκτης Τίτλος Τύπος [ Έτος(Asc)]
Φίλτρα: Συντάκτης is Mikhailidis, Dimitri P  [Clear All Filters]
2021
Anagnostis, P., Papanikolaou D., Ioannidou P. G., Bosdou J. K., Mikhailidis D. P., Hatzimouratidis K., et al. (2021).  The effect of statins on semen parameters in patients with hypercholesterolemia: A systematic review.. Andrology. 9(5), 1504-1511.
2020
Anagnostis, P., Vaitsi K., Kleitsioti P., Mantsiou C., Pavlogiannis K., Athyros V. G., et al. (2020).  Efficacy and safety of statin use in children and adolescents with familial hypercholesterolaemia: a systematic review and meta-analysis of randomized-controlled trials.. Endocrine.
Anagnostis, P., Goulis D. G., & Mikhailidis D. P. (2020).  Endocrine Disease as a Cause of Cardiovascular Disease: Current Perspectives.. Curr Pharm Des. 26(43), 5547-5550.
Anagnostis, P., Vaitsi K., Mintziori G., Goulis D. G., & Mikhailidis D. P. (2020).  Non-coronary atherosclerotic cardiovascular disease in patients with familial hypercholesterolaemia.. Curr Med Res Opin. 1-10.
Anagnostis, P., Vaitsi K., Mintziori G., Goulis D. G., & Mikhailidis D. P. (2020).  Vascular surgical procedures in patients with familial hypercholesterolaemia: is it too late?. Curr Med Res Opin. 36(8), 1255.
2019
Katsiki, N., Anagnostis P., Kotsa K., Goulis D. G., & Mikhailidis D. P. (2019).  Obesity, Metabolic Syndrome and the Risk of Microvascular Complications in Patients with Diabetes mellitus.. Curr Pharm Des. 25(18), 2051-2059.
2017
Katsiki, N., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2017).  Semaglutide, lipid-lowering drugs, and NAFLD.. Lancet Diabetes Endocrinol. 5(5), 329-330.
Athyros, V. G., Alexandrides T. K., Bilianou H., Cholongitas E., Doumas M., Ganotakis E. S., et al. (2017).  The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement.. Metabolism. 71, 17-32.
2016
Athyros, V. G., & Mikhailidis D. P. (2016).  High incidence of metabolic syndrome further increases cardiovascular risk in patients with type 2 diabetes. Implications for everyday practice.. J Diabetes Complications. 30(1), 9-11.
Katsiki, N., Doumas M., & Mikhailidis D. P. (2016).  Lipids, Statins and Heart Failure: An Update.. Curr Pharm Des. 22(31), 4796-4806.
Athyros, V. G., Katsiki N., Karagiannis A., & Mikhailidis D. P. (2016).  Statins and non-alcoholic steatohepatitis.. J Hepatol. 64(1), 241-2.
Katsiki, N., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2016).  Statins and Type 2 Diabetes Mellitus: An Update After 1 Year.. Curr Pharm Des. 22(18), 2723-5.
2015
Athyros, V. G., Tziomalos K., Katsiki N., Doumas M., Karagiannis A., & Mikhailidis D. P. (2015).  Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update.. World J Gastroenterol. 21(22), 6820-34.
Katsiki, N., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2015).  Contrast-Induced Nephropathy: An "All or None" Phenomenon?. Angiology. 66(6), 508-13.
Athyros, V. G., Tziomalos K., Karagiannis A., & Mikhailidis D. P. (2015).  Genetic, epidemiologic and clinical data strongly suggest that fasting or non-fasting triglycerides are independent cardiovascular risk factors.. Curr Med Res Opin. 31(3), 435-8.
Athyros, V. G., Katsiki N., Karagiannis A., & Mikhailidis D. P. (2015).  High-intensity statin therapy and regression of coronary atherosclerosis in patients with diabetes mellitus.. J Diabetes Complications. 29(1), 142-5.
Kargiotis, K., Athyros V. G., Giouleme O., Katsiki N., Katsiki E., Anagnostis P., et al. (2015).  Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndrome.. World J Gastroenterol. 21(25), 7860-8.
Athyros, V. G., Katsiki N., Karagiannis A., & Mikhailidis D. P. (2015).  Short-, mid-, and long-term benefits of peri-procedural high-intensity statin administration in patients undergoing percutaneous coronary intervention.. Curr Med Res Opin. 31(2), 191-5.
Katsiki, N., Athyros V. G., & Mikhailidis D. P. (2015).  Statin therapy and cardiovascular outcomes after coronary revascularization in the elderly.. Atherosclerosis. 238(2), 182-4.
Athyros, V. G., Katsiki N., Karagiannis A., & Mikhailidis D. P. (2015).  Statins can improve proteinuria and glomerular filtration rate loss in chronic kidney disease patients, further reducing cardiovascular risk. Fact or fiction?. Expert Opin Pharmacother. 16(10), 1449-61.
2014
Athyros, V. G., Katsiki N., Karagiannis A., & Mikhailidis D. P. (2014).  The 2013 American College of Cardiology/American Heart Association guidelines for the treatment of dyslipidemia: mind the gaps!. Curr Med Res Opin. 30(9), 1701-5.
Mikhailidis, D. P., & Athyros V. G. (2014).  Acute kidney injury: Short-term statin therapy for prevention of contrast-induced AKI.. Nat Rev Nephrol. 10(1), 8-9.
Athyros, V. G., Katsiki N., Karagiannis A., & Mikhailidis D. P. (2014).  Are statins 'IDEAL' for non-alcoholic fatty liver disease?. Curr Med Res Opin. 30(2), 229-31.
Katsiki, N., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2014).  Characteristics other than the diagnostic criteria associated with metabolic syndrome: an overview.. Curr Vasc Pharmacol. 12(4), 627-41.
Mikhailidis, D. P., & Athyros V. G. (2014).  Dyslipidaemia in 2013: New statin guidelines and promising novel therapeutics.. Nat Rev Cardiol. 11(2), 72-4.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές